Alex Reyentovich MD
Heart Failure & Transplantation, Cardiovascular Disease Genetics, Cardiac Critical Care
Professor of Medicine, NYU Grossman School of Medicine
Join to View Full Profile
530 1st AvenueSkirball 9NNew York, NY 10016
Phone+1 646-501-0119
Dr. Reyentovich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alex Reyentovich is a cardiologist based in New York, NY, specializing in adult congenital heart disease, heart failure and transplantation, as well as cardiac critical care. He completed his fellowship in cardiovascular disease and residency in internal medicine at NewYork-Presbyterian Hospital (Columbia Campus), following his medical degree from the Geisel School of Medicine at Dartmouth. Currently, he serves as a Professor of Medicine at NYU Langone Health. His expertise includes cardiomyopathies, sarcoidosis-related cardiomyopathy, transplant cardiology, sarcoidosis, and congestive heart failure. Dr Reyentovich currently serves as the Director of the Heart Failure and Heart Transplant Program at NYU Langone Health and is the former Director of the LVAD and Amyloidosis Program.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Cardiovascular Disease, 2006 - 2009- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2002 - 2006
Geisel School of Medicine at DartmouthClass of 2002
Certifications & Licensure
NJ State Medical License 2022 - 2025
NY State Medical License 2004 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- HCV Positive Heart Donors Start of enrollment: 2018 Jan 05
Publications & Presentations
PubMed
- Spinal Cord Infarction as a Complication of VA-ECMO With Microaxial Flow Pump in Cardiogenic Shock.Arushi Singh, Syed Zain Ali, Kelly A Drozdowicz, Amit Alam, Randal I Goldberg
JACC. Case Reports. 2025-04-02 - Outcomes of Donation After Circulatory Death Heart Transplantation Using Normothermic Regional Perfusion.Akshay Kumar, Amit Alam, Michael Dorsey, Les James, Syed Hussain
Annals of Thoracic Surgery Short Reports. 2025-03-01 - 1 citationsWaitlist mortality for patients with cardiac allograft vasculopathy under the 2018 OPTN donor heart allocation system.Bernard S Kadosh, Suhani S Patel, Sharnendra K Sidhu, Allan B Massie, Stephanie Golob
The Journal of Heart and Lung Transplantation. 2025-03-01
Press Mentions
Donor Hearts from Patients with COVID Tied to Lower SurvivalMay 23rd, 2023- Donor Hearts from Patients with COVID Tied to Lower SurvivalMay 23rd, 2023
- Two Times 200: Heart & Lung Transplant Programs Surpass 200th Transplant MilestonesAugust 23rd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
